POS-442 DISCOVERY OF CHK-336: A FIRST-IN-CLASS, LIVER-TARGETED, SMALL MOLECULE INHIBITOR OF LACTATE DEHYDROGENASE FOR THE TREATMENT OF PRIMARY HYPEROXALURIA

POS-442 DISCOVERY OF CHK-336: A FIRST-IN-CLASS, LIVER-TARGETED, SMALL MOLECULE INHIBITOR OF LACTATE DEHYDROGENASE FOR THE TREATMENT OF PRIMARY HYPEROXALURIA

Bibliographic Details
Main Authors: J. COX, M.O. Boily, A. Caron, O. Chong, J. Ding, V. Dumais, S. Gaudreault, R. Gomez, J. Guthrie, A. King, R. Oballa, T. Sheng, J. Surendradoss, J. Wu, D. Powell
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024921006136

Internet

http://www.sciencedirect.com/science/article/pii/S2468024921006136

Similar Items